10-76885695-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001161352.2(KCNMA1):​c.*1571C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.551 in 984,658 control chromosomes in the GnomAD database, including 151,938 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.49 ( 19488 hom., cov: 31)
Exomes 𝑓: 0.56 ( 132450 hom. )

Consequence

KCNMA1
NM_001161352.2 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.252

Publications

7 publications found
Variant links:
Genes affected
KCNMA1 (HGNC:6284): (potassium calcium-activated channel subfamily M alpha 1) This gene encodes the alpha subunit of calcium-activated BK channel. The encoded protein is involved in several physiological processes including smooth muscle contraction, neurotransmitter release and neuronal excitability. Mutations in this gene are associated with a spectrum of neurological disorders including Paroxysmal Nonkinesigenic Dyskinesia 3, Idiopathic Generalized Epilepsy 16 and Liang-Wang syndrome. [provided by RefSeq, Aug 2022]
KCNMA1 Gene-Disease associations (from GenCC):
  • generalized epilepsy-paroxysmal dyskinesia syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, G2P, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • Liang-Wang syndrome
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • cerebellar atrophy, developmental delay, and seizures
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 10-76885695-G-A is Benign according to our data. Variant chr10-76885695-G-A is described in ClinVar as [Benign]. Clinvar id is 300933.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.576 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNMA1NM_001161352.2 linkc.*1571C>T 3_prime_UTR_variant Exon 28 of 28 ENST00000286628.14 NP_001154824.1 Q12791-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNMA1ENST00000286628.14 linkc.*1571C>T 3_prime_UTR_variant Exon 28 of 28 1 NM_001161352.2 ENSP00000286628.8 Q12791-1

Frequencies

GnomAD3 genomes
AF:
0.494
AC:
75009
AN:
151776
Hom.:
19479
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.383
Gnomad AMI
AF:
0.590
Gnomad AMR
AF:
0.417
Gnomad ASJ
AF:
0.642
Gnomad EAS
AF:
0.301
Gnomad SAS
AF:
0.356
Gnomad FIN
AF:
0.580
Gnomad MID
AF:
0.620
Gnomad NFE
AF:
0.580
Gnomad OTH
AF:
0.519
GnomAD4 exome
AF:
0.562
AC:
467923
AN:
832764
Hom.:
132450
Cov.:
32
AF XY:
0.562
AC XY:
216310
AN XY:
384588
show subpopulations
African (AFR)
AF:
0.366
AC:
5783
AN:
15780
American (AMR)
AF:
0.354
AC:
347
AN:
980
Ashkenazi Jewish (ASJ)
AF:
0.646
AC:
3329
AN:
5152
East Asian (EAS)
AF:
0.285
AC:
1033
AN:
3630
South Asian (SAS)
AF:
0.381
AC:
6266
AN:
16452
European-Finnish (FIN)
AF:
0.623
AC:
172
AN:
276
Middle Eastern (MID)
AF:
0.562
AC:
910
AN:
1620
European-Non Finnish (NFE)
AF:
0.572
AC:
435538
AN:
761584
Other (OTH)
AF:
0.533
AC:
14545
AN:
27290
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
9754
19508
29262
39016
48770
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16474
32948
49422
65896
82370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.494
AC:
75032
AN:
151894
Hom.:
19488
Cov.:
31
AF XY:
0.487
AC XY:
36163
AN XY:
74218
show subpopulations
African (AFR)
AF:
0.382
AC:
15817
AN:
41382
American (AMR)
AF:
0.416
AC:
6353
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.642
AC:
2229
AN:
3470
East Asian (EAS)
AF:
0.300
AC:
1550
AN:
5160
South Asian (SAS)
AF:
0.357
AC:
1715
AN:
4798
European-Finnish (FIN)
AF:
0.580
AC:
6116
AN:
10546
Middle Eastern (MID)
AF:
0.639
AC:
188
AN:
294
European-Non Finnish (NFE)
AF:
0.580
AC:
39437
AN:
67952
Other (OTH)
AF:
0.516
AC:
1089
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1815
3631
5446
7262
9077
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
666
1332
1998
2664
3330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.554
Hom.:
27532
Bravo
AF:
0.477
Asia WGS
AF:
0.314
AC:
1092
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Generalized epilepsy-paroxysmal dyskinesia syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.87
DANN
Benign
0.69
PhyloP100
0.25
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10762733; hg19: chr10-78645453; API